CABA

Conviction 11HealthcareScan · Thu, Sep 24, 2026

Cabaletta Bio, Inc. (CABA) closed at $2.16 (-2.93%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 18, -48.1% from its 52-week high, -2.5% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

CABA$2.16-2.93%

ResistanceSupportVol 14

Vol MA14 6.49M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Cabaletta Bio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cabalettabio.com ↗

Price2.16

Change-2.93%

Gap-0.23%

Rel volume1.12×

Avg volume6.15M

Avg $ vol17.42M

SMA 202.88

SMA 502.85

SMA 2002.93

Price vs 50-24.47%

Price vs 200-26.36%

MA stackbearish

50/200 crossdeath · 7d

Supertrenddown · 2.80

RSI (14)31

MACD hist-0.09

MACD cross—

Stoch %K / %D6 / 4

ADX (14)25

+DI / −DI14 / 36

RSI divergence—

MACD divergence—

ATR %10.19%

ADR %8.41%

52w high4.15

52w low2.04

From 52w high-48.07%

Above 52w low+5.64%

New 52w highNo

SqueezeOff

Bollinger width59.24%

%B0.08

Donchian pos5.62%

Donchian high3.75

Donchian low2.06

AVWAP (52w high)3.06

vs AVWAP high-29.50%

AVWAP (52w low)3.05

vs AVWAP low-29.34%

OBV trendDown

Chaikin MF (20)-0.30

Today vs 20d1.12×

Avg vol (14d)6.49M

Avg vol (20d)6.15M

Avg $ vol (20d)17.42M

Market cap365.37M

RS Rating18 / 99

RS 3m (vs SPY)-30.69%

RS 6m (vs SPY)-39.30%

RS line new highNo

Trend template2/8

Technical rank10.2

1 week-16.47%

1 month-33.07%

3 months-26.20%

6 months-22.48%

1 year-10.95%

YTD-2.49%

P/E-2.18

P/B1.74

P/S—

P/FCF-2.76

EPS-2.10

Div yield—

ROE-79.71%

ROA-65.38%

Debt/Eq—

Current5.79

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-44.87%

Price target14.67

Target upside580.74%

Analyst ratingBuy

Institutional96.14%

Ent. value140.27M

Revenue—

Net income-51.02M

Gross profit—

Free cash flow-132.31M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out163.05M

Employees158

ListedFri, Oct 25, 2019

Free float105.3M

Float %94.6%

Short interest41.44M

Days to cover8.3d

Short volume44.3%

Squeeze score70 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.34 vs −$0.37

Last surprise+8.1% beat

Setup gradeD

Conviction11 / 100

Pattern quality—

Tech rank10.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.60

Support2.54

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Aug 26
1 scan
→
Breaking out now
Aug 27
1 scan

Congress activity

Disclosed STOCK Act trades in CABA

All disclosures →

No recent disclosed trades by Congress in CABA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CABA

Insider	Side	Shares	Value	Traded	Filed
Brun Scott C. Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
HENRIQUES RICHARD C JR Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Simon Mark Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Bollard Catherine Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Tomasello Shawn Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10

SEC filings

EDGAR filings in CABA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.